ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
General Health & Fitness
Health & Wellness
Genetic Testing & the Choice of Anidepressant
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="CoastWatcher" data-source="post: 106383" data-attributes="member: 2624"><p>For over 30 years, they've been praised to the sky and vilified as virtual poisons. Antidepressant - few drugs, since the era of antibiotics arrived in the wake of the second world war, have received as much media attention. At the recent annual meeting of the American Psychiatric Association, a study was presented that is likely to continue the debate. It is argued that patients with treatment-resistant, major depressive disorder (MDD) were 30% more likely to respond to treatment, and 50% more likely to achieve remission, when their medication selection was guided by the GeneSight psychotropic genetic test. </p><p></p><p></p><p>Currently, trial-and-error prescribing of antidepressants is the norm. Such a practice is a contributing factor in treatment failure and increases costs. The GeneSight test combines personal genetic data with medication information to tailor which antidepressant should be prescribed. The information involves 12 genes and 56 medications. DNA samples are taken with cheek swabs, sent to a laboratory, and returned in 36 hours with a significant gene interactions identified.</p><p></p><p></p><p>The study included 1167 outpatients with moderate to very severe, treatment-resistant depression for whom at least one antidepressant had failed. Most participants had at least three treatment failures. At eight weeks, symptom improvement was seen in the GeneSight cohort, and improvements in rates of response and remission were "significantly greater" in the GeneSight cohort. </p><p></p><p>"Genetic Test Identifies Best Antidepressant," <em>Medscape, May 7, 2018, <a href="https://www.medscape.com/viewarticle/896259?nlid=122268_3901&src=wnl_newsalrt_180507_MSCPEDIT&uac=291811EY&impID=1626579&faf=1" target="_blank">https://www.medscape.com/viewarticle/896259?nlid=122268_3901&src=wnl_newsalrt_180507_MSCPEDIT&uac=291811EY&impID=1626579&faf=1</a></em></p></blockquote><p></p>
[QUOTE="CoastWatcher, post: 106383, member: 2624"] For over 30 years, they've been praised to the sky and vilified as virtual poisons. Antidepressant - few drugs, since the era of antibiotics arrived in the wake of the second world war, have received as much media attention. At the recent annual meeting of the American Psychiatric Association, a study was presented that is likely to continue the debate. It is argued that patients with treatment-resistant, major depressive disorder (MDD) were 30% more likely to respond to treatment, and 50% more likely to achieve remission, when their medication selection was guided by the GeneSight psychotropic genetic test. Currently, trial-and-error prescribing of antidepressants is the norm. Such a practice is a contributing factor in treatment failure and increases costs. The GeneSight test combines personal genetic data with medication information to tailor which antidepressant should be prescribed. The information involves 12 genes and 56 medications. DNA samples are taken with cheek swabs, sent to a laboratory, and returned in 36 hours with a significant gene interactions identified. The study included 1167 outpatients with moderate to very severe, treatment-resistant depression for whom at least one antidepressant had failed. Most participants had at least three treatment failures. At eight weeks, symptom improvement was seen in the GeneSight cohort, and improvements in rates of response and remission were "significantly greater" in the GeneSight cohort. "Genetic Test Identifies Best Antidepressant," [I]Medscape, May 7, 2018, [URL]https://www.medscape.com/viewarticle/896259?nlid=122268_3901&src=wnl_newsalrt_180507_MSCPEDIT&uac=291811EY&impID=1626579&faf=1[/URL][/I] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
General Health & Fitness
Health & Wellness
Genetic Testing & the Choice of Anidepressant
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top